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We investigated metabolic changes during brain death (BD) using hyperpolarized mag-
netic resonance (MR) spectroscopy and ex vivo graft glucose metabolism during normo-
thermic isolated perfused kidney (IPK) machine perfusion. BD was induced in mechanically 
ventilated rats by inflation of an epidurally placed catheter; sham-operated rats served as 
controls. Hyperpolarized [1-13C]pyruvate MR spectroscopy was performed to quantify pyru-
vate metabolism in the liver and kidneys at 3 time points during BD, preceded by injecting 
hyperpolarized[1-13C]pyruvate. Following BD, glucose oxidation was measured using tritium-
labeled glucose (d-6-3H-glucose) during IPK reperfusion. Quantitative polymerase chain reac-
tion and biochemistry were performed on tissue/plasma. Immediately following BD induction, 
lactate increased in both organs (liver: eµd0.21, 95% confidence interval [CI] [−0.27, −0.15]; 
kidney: eµd0.26, 95% CI [−0.40, −0.12]. After 4 hours of BD, alanine production decreased in 
the kidney (eµd0.14, 95% CI [0.03, 0.25], P < .05). Hepatic lactate and alanine profiles were 
significantly different throughout the experiment between groups (P < .01). During IPK perfu-
sion, renal glucose oxidation was reduced following BD vs sham animals (eµd0.012, 95% CI 
[0.004, 0.03], P < .001). No differences in enzyme activities were found. Renal gene expres-
sion of lactate-transporter MCT4 increased following BD (P < .01). In conclusion, metabolic 
processes during BD can be visualized in vivo using hyperpolarized magnetic resonance imag-
ing and with glucose oxidation during ex vivo renal machine perfusion. These techniques can 
detect differences in the metabolic profiles of the liver and kidney following BD.
K E Y W O R D S
animal models, basic (laboratory) research/science, donors and donation: donation after brain 
death (DBD), graft survival, kidney (allograft) function/dysfunction, kidney transplantation/
nephrology, liver allograft function/dysfunction, liver transplantation/hepatology, organ 
procurement and allocation, translational research/science
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1  | INTRODUC TION
The global shortage of donor organs results in almost 115 000 peo-
ple in the United States and 15 000 people in Europe on the organ 
waiting list.1,2 For most of these patients, organ transplantation 
would mean a significant improvement of their survival and quality 
of life.3 Most organs worldwide are obtained from brain-dead organ 
donors.3 However, brain death (BD) causes major changes in donor 
physiology,4-7 leading to impaired graft function, higher rejection 
rates, and inferior long-term outcomes after transplantation com-
pared to living-donor transplantations.7,8 Therefore, it is important 
to improve our understanding of BD-induced injuries. This would 
allow us to treat or precondition organs, in the donor or during organ 
preservation.
Donor BD affects systemic as well as organ-specific metabolism. 
In plasma, glucose levels decrease yet lactate and fatty acid levels in-
crease.9-11 In both the liver and kidneys, tissue injury increases while 
adenosine triphosphate (ATP) levels decline.9,12-15 However, a prior 
study by our group suggests that the underlying mechanisms vary.9 
In the kidneys, anaerobic metabolism increased, resulting in more 
pyruvate breakdown and decreased glucose production.9 As BD 
causes decreased renal perfusion and increased oxidative stress,9,12 
this is likely the result of renal hypoxia. Meanwhile in the liver, gly-
cogen stores declined while glycolysis and oxygen consumption in-
creased9,10 (Figure 1). Also, several mitochondrial peptides involved 
in fatty acid oxidation and substrate transport increased. In contrast 
to the kidneys, the liver seems to respond to increasing energy de-
mands by altering its metabolic profile.9 These metabolic changes 
are potentially significant, as the pretransplant metabolic status 
of the liver and kidney has been correlated to posttransplant graft 
viability.16-20 This might be explained by the fact that (changes in) 
metabolism can influence cell survival, cell growth, and cell death 
pathways including autophagy and apoptosis.21-23
Cellular metabolism of 13C-labeled (enriched) molecules can be 
monitored noninvasively using a novel technique called hyperpolarized 
magnetic resonance imaging (MRI). Hyperpolarization increases the 
sensitivity of the MRI system more than 10 000-fold, using techniques 
such as dynamic nuclear polarization.24,25 Labeling of 13C-pyruvate 
F I G U R E  1   Overview of metabolic changes in the liver and kidney following brain death. All changes depicted in green represent an 
increase in activity or level, whereas all changes marked in red denote decreased activity or levels.9 All compounds marked in orange are 
involved in the metabolization of pyruvate into its metabolites: the pyruvate-alanine (or Cahill) cycle involving enzyme ALT, the pyruvate-
lactate cycle involving LDH as the last step of glycolysis in the absence of oxygen, pyruvate decarboxylation involving the transformation of 
pyruvate to acetyl-CoA involving PDH, and finally the formation of bicarbonate (HCO3) from carbon dioxide (CO2) as an end-product of the 
mitochondrial TCA cycle. ALT, alanine aminotransferase; LDH, lactate dehydrogenase; PDH, pyruvate dehydrogenase; TCA, tricarboxylic 
acid
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allows for real-time metabolic mapping of pyruvate as well as its 
metabolites, including lactate, alanine, and bicarbonate (Figure 1).26 
Visualization of these metabolites using hyperpolarized 13C-pyruvate 
MRI has already shown promise in diagnosing and monitoring early 
renal functional changes27,28 and has recently been translated to 
humans.29
There are currently no good quantitative biomarkers to be 
used before transplantation that correlate with organ quality. 
Furthermore, most clinically tested interventions in the deceased 
donor have not improved organ quality or survival after transplan-
tation.30,31 As mentioned, previous reports have demonstrated that 
organ-specific, metabolic changes already occur within the brain-
dead donor.9-15 Here we investigated metabolic pathophysiological 
changes in the brain-dead donor using hyperpolarized MR spectros-
copy in the liver and kidney and ex vivo graft glucose metabolism 
during normothermic kidney machine perfusion. We hypothesized 
that metabolism would differ between BD animals and controls.
2  | MATERIAL S AND METHODS
2.1 | BD model
Twenty-two male, Fisher 344 rats were randomized into 3 groups: a 
sham-operated (sham) (n = 8), a BD (n = 8), and a BD control group (rep-
resented as BD [T = 0], n = 6). The BD and sham groups were exposed 
to an experimental duration of 4 hours of BD, whereas the BD control 
group was terminated immediately after BD induction (Figure 2). The 
BD control group was added to correlate differences in MRI measure-
ments to changes such as enzyme of gene expression in tissue. The BD 
model previously described by Kolkert et al was used32 with several ad-
aptations to ensure MRI compatibility,9 described in more detail in the 
Supplementary Material. Briefly, animals were anesthetized with sevo-
flurane, intubated via a tracheostomy and ventilated (MR-compatible 
Small Animal Ventilator; SA Instrument, Inc, New York, NY). Through 
an arterial and venous cannula, volume was replaced and the mean 
arterial pressure (MAP) was measured. BD was induced by inflation 
of a Fogarty catheter in the epidural space (Edwards Lifesciences 
Co, Irvine, CA). Intracranial pressure (ICP) was monitored through a 
contralaterally placed 24G cannula. BD was confirmed when the ICP 
superseded the MAP and animals were solely ventilated with a FIO2 
of 50%. Sham animals underwent an identical procedure, except for 
insertion of the Fogarty catheter while anesthesia lasted the entire 
4 hours of the experiment. After 4 hours, the experiment was termi-
nated and the organs, plasma, and urine were retrieved.
2.2 | MRI assessment of 13C-pyruvate metabolism
We used a 9.4 T preclinical MR system (Agilent, Santa Clara, CA) 
with VnmrJ 4.0A (Agilent) with a dual tuned 13C/1H volume rat coil 
(Doty Scientific, Columbia, MO).33,34 After a 1H anatomical MR scan 
to determine the location of the liver and kidneys, hyperpolarized [1-
13C]pyruvate MR spectroscopy was performed to quantify pyruvate 
metabolism in the liver and kidneys at 3 different time points: at the 
start of BD (T = 0), after 2 hours (T = 2), and after 4 hours (T = 4, 
Figure 2), preceded each time by an injection of 1.5 mL of a 85 mmol 
hyperpolarized [1-13C]pyruvate, pH neutral and isotonic solution (de-
tails can be found in the Supplementary Material). [1-13C]pyruvate 
was polarized in a SpinLab (GE Healthcare).33,35 Each time, 1.5 mL 
[1-13C]pyruvate solution was injected into the femoral vein in 10 sec-
onds, after which scanning was initiated. The area under the curve 
of the spectral peaks of [1-13C]pyruvate and each of the metabolites 
was calculated for the total signal using MATLAB. More details can 
be found in the Supplementary Material.
2.3 | Reperfusion model and glucose oxidation 
in the IPK
Following 4 hours of BD, the left kidney was normothermically per-
fused for 90 minutes in an isolated perfused kidney (IPK) device 
(Figure S1),36 described in more detail in the Supplementary Material. 
Briefly, the IPK system is a pressure- (100 mm Hg) and temperature- 
(37°C) controlled perfusion system that allows for pulsatile perfusion 
of the kidney via arterial and venous cannulas with an oxygenated 
F I G U R E  2   Experimental overview, where T = −2 marks the beginning of surgery, T = −0.5 the beginning of BD induction, T = 0 the 
beginning of the BD period, and the subsequent hours of the total BD duration. At T = 0, T = 2, and T = 4, hyperpolarized [1-13C]pyruvate MR 
spectroscopy was performed following an injection of [1-13C]pyruvate at each time point. The BD control group was terminated following 
the first round of MR spectroscopy (shortly after T = 0). BD, brain death; MR, magnetic resonance
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(95% O2, 95% CO2) perfusion medium. During the experiment, flow 
and (pre- and postrenal) oxygenation were recorded at 10-minute in-
tervals. Sampling of perfusate and urine was done after 0, 15, 30, 60, 
and 90 minutes of perfusion. After 90 minutes, the kidney was discon-
nected and stored at −80°C for further analyses.
Rates of glucose oxidation were measured during reperfusion 
using a tritium-labeled glucose isotope (d-6-3H-glucose) in accor-
dance with a protocol modified from isolated heart perfusions37,38 
and described in more detail in the Supplementary Material. A 
buffer volume of 100 mL (5 μL d-6-3H-glucose/100 mL KH buffer) 
was recirculated. The oxidation of exogenous glucose was assessed 
measuring the amount of 3H2O, liberated from the oxidation of d-
[6-3H]-glucose in the citric acid cycle. 3H2O was separated using 
anion exchange chromatography on AG 1-X8 resin columns (Bio-Rad, 
Hercules, CA ) and quantified using beta-scintillation on a TriCarb 
2900TR liquid scintillation analyzer (Packard, Shelton, CT ) in disinte-
grations per minute (dpm). The final glucose concentration was pre-
sented as the baseline activity of the perfusate divided by the dpm, 
corrected for the wet weight (mass) of each kidney and the flow.
2.4 | Plasma and urine injury markers
Plasma levels of aspartate transaminase (AST), alanine aminotrans-
ferase (ALT), creatinine, urea, lactate dehydrogenase (LDH), glucose, 
and lactate, and urine creatinine were determined at the clinical 
chemistry laboratory of the University Medical Centre Groningen 
according to standard procedures.
2.5 | Enzyme activity assays and gene expression
The enzyme activities of LDH, pyruvate dehydrogenase (PDH), and 
ALT from liver and kidney tissue were determined using enzyme 
activity assay kits according to the manufacturer's instructions39-42 
(Sigma-Aldrich, Zwijndrecht, The Netherlands).
For gene expression, RNA was isolated from whole liver and kid-
ney sections using TRIzol (Life Technologies, Carlsbad,  CA) using 
a method described in more detail in the Supplementary Material.9 
Primer sets used to amplify LDHA, MCT1, and MCT4 are outlined 
in Table S1. Gene expression was normalized to the mean mRNA 
β-actin content and pooled cDNA from brain-dead rats used as an 
internal reference. Real-time polymerase chain reaction was done 
according to methods described previously9 and in more detail in 
the Supplementary Material. Results are expressed as 2−△△CT (CT: 
threshold cycle).
2.6 | Tissue ATP levels
ATP content was determined as a measure of the organ energy sta-
tus in 50 mg of frozen hepatic and renal tissue slices, using standard 
methods described in detail in the Supplementary Material.9
2.7 | Oxidative stress markers
Oxidative damage was determined through estimation of the lipid 
peroxidation product malondialdehyde (MDA) in plasma as well as 
tissue homogenates (each 20 µL). Levels of MDA were measured 
fluorescently after binding of MDA to thiobarbituric acid reactive 
substances (TBARS), which are formed as a byproduct of lipid per-
oxidation when reactive oxygen species react with lipids in plasma 
membranes. TBARS in plasma and tissue were determined using 
methods described in more detail in the Supplementary Material.9
2.8 | Statistical analysis
For the MRI data, a mixed-effects regression model with a restricted 
maximum likelihood method with repeated measures over time was 
used to analyze the impact of treatment (BD or sham) on different 
metabolites or IPK parameters. Data were checked for a normal dis-
tribution of variances. If this assumption was not met, data transfor-
mations were applied or extreme values removed from the analysis 
(see below). The model included fixed effects of time, treatment, the 
interaction between time and treatment, and a random effect that 
took between-rat variations into account (Stata/IC 12.1 for Mac, 
Stata-Corp LP, College Station, TX). For the IPK data, a mixed-effects 
analysis of variance was performed to check for significant interac-
tion effects. If the interaction was not significant, we checked for 
main effects of group (BD or sham) or time. If significant differences 
were found, Bonferroni correction for 5 multiple comparisons was 
done to test for differences between individual groups (IBM SPSS 
Statistics 23, Armonk, NY). Results are presented as the estimated 
mean difference between groups (model coefficient, eµd), with the 
95% confidence interval (CI) and the P value.
For the enzyme activity assay, ATP, MDA, and gene expression 
analyses, data were checked for a normal distribution. When vari-
ances of the dependent variable were equal across groups and there 
were no outliers, a pooled Student t test was done. If data were not 
normally distributed, Mann-Whitney tests were done to compare 
between 2 groups individually (IBM SPSS Statistics 23). When mul-
tiple groups were compared, Bonferroni corrections for 3 multiple 
comparisons was done. Each separate animal is presented as a dot 
or square in each of the figures (with the exception of Figure S1). 
Extreme outliers were identified according to Tukey's hinges as 
xi ≥ Q3+2 × step or xi ≤ H1-2 × step and removed from the analyses. 
Statistical tests were 2-tailed and P < .05 was regarded as statisti-
cally significant. Results are presented as mean ± standard deviation.
3  | RESULTS
3.1 | BD parameters
Throughout the experiment, the MAP was measured continuously. 
BD was confirmed based on a rise in MAP following the drop in blood 
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pressure that is characteristic for the slow-induction BD model. The 
induction of BD showed a uniform MAP pattern in all animals that 
was in agreement with prior BD studies,9,13,32,43 with a mean time to 
declare BD of 25 ± 3.1 minutes (Figure S2). To maintain a MAP higher 
than 80 mm Hg, the use of colloid HAES was required in 3 brain-
dead and 3 sham animals (0.38 ± 0.55 vs 0.44 ± 0.63 mL, P = .85), 
and the use of noradrenaline was required in 2 brain-dead animals 
(0.50 ± 0.87 mL, P = .17).
3.2 | Plasma injury markers
Several hepatic (AST, ALT, and LDH) and renal injury markers (urea 
and creatinine) were assessed to validate our model and to evaluate 
the effect of BD on tissue injury. In plasma of brain-dead animals, 
AST after 4 hours (T = 4) and creatinine immediately after BD induc-
tion (T = 0) were significantly higher compared to sham animals (AST: 
186 ± 87 vs 104 ± 76 U/L, P = .017 and creatinine: 43.3 ± 2.7 vs 
28.4 ± 5.3, P < .001, Figure 3). Urine creatinine was significantly lower 
in brain-dead animals at T = 4 compared to sham animals (4.0 ± 0.7 vs 
8.8 ± 1.2 mmol/L, P < .001, Figure 3). Plasma urea was significantly 
lower in BD animals at T = 0 compared to sham animals (7.7 ± 0.6 vs 
10.6 ± 0.9 mmol/L, P < .001, Figure 3). Finally, AST, ALT, LDH, and urea 
were significantly higher in brain-dead animals at T = 4 (vs brain-dead 
animals at T = 0, AST: 186 ± 86.9 vs 73.8 ± 76.3 U/L, P = .01; ALT: 
144 ± 101 vs 43.8 ± 64.2 U/L, P < .01, LDH: 580 ± 514 vs 265 ± 216 
U/L, P = .01; urea: 11.1 ± 1.8 vs 7.7 ± 0.9 mmol/L, P < .001, Figure 3), 
whereas urine creatinine was significantly lower than in brain-dead 
animals at T = 0 (4.0 ± 0.7 vs 8.2 ± 1.2 mmol/L, P < .01, Figure 3).
3.3 | MRI assessment of 13C-pyruvate metabolism
Enriched 13C-pyruvate was injected repetitively to evaluate the met-
abolic profile at T = 0, T = 2, and T = 4 hours by assessing the relative 
conversion of pyruvate into lactate, alanine, and bicarbonate. The 
metabolic profiles of the liver and kidneys are portrayed in Figure 4. 
In order to determine the relative metabolic shift, each metabolite 
was normalized to the signal intensity of the sum of the products 
(ie, lactate, alanine, and bicarbonate). At T = 0, brain-dead animals 
showed significantly higher lactate levels, and significantly lower 
alanine levels in both the liver and kidney compared to sham ani-
mals (liver lactate T = 0: eµd −0.21, 95% CI [−0.27, −0.15], P < .001; 
liver alanine T = 0: eµd0.14, 95% CI [0.07, 0.23], P < .001; kidney 
lactate T = 0: eµd−0.26, 95% CI [−0.40; −0.12], P < .001; kidney ala-
nine T = 0: eµd0.24, 95% CI [0.06; 0.42], P < .001, Figure 4). In the 
kidney, alanine levels were significantly lower in brain-dead com-
pared to sham animals at T = 4 (eµd0.14 [0.03; 0.25], P = .02), and 
F I G U R E  3   BD reduced hepatic and renal function. Plasma levels of (A) AST, (B) ALT, (C) LDH, (D) urea, and (E) plasma and (F) urine 
creatinine, determined after 4 h (at T = 4) of experimental time or immediately after BD induction (at T = 0). Results are presented 
as mean ± SD, n = 8 in the sham and BD (T = 4) group, and n = 6 in the BD (T = 0) group. ALT, alanine transaminase; AST, aspartate 
transaminase; BD, brain death; LDH, lactate dehydrogenase.
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bicarbonate levels were significantly lower at T = 0 and T = 4 hours 
(T = 0: eµd2.36, 95% CI [1.62; 3.10], P < .001, T = 4: eµd0.62, 95% 
CI [0.05; 1.19], P = .04, Figure 4). Furthermore, the interaction term 
showed a significantly different effect of time on lactate and alanine 
levels in the liver (P < .001 and P < .01, respectively, Figure 4). In the 
kidney, the interaction term was significantly different for bicarbo-
nate, indicating this metabolite differs between groups (BD vs sham) 
over the course of time.
3.4 | Kidney function and glucose oxidation in 
isolated perfused kidney model
Renal function was assessed in an isolated perfused kidney model 
following BD by assessing the flow, ultrafiltrate production, intra-
renal vascular resistance (IRR),44 and GFR (creatinine clearance). 
We found a significant interaction of flow and IRR, indicating a 
significantly different effect of time on flow and IRR in brain-dead 
versus sham animals (flow: eµd 0.93, 95% CI [−1.14, 3.00], P < .01; 
IRR: eµd2.02, 95% CI [−0.48, 4.53], P < .001, Figure 5). In brain-dead 
animals, the IRR was significantly lower at T = 0 compared to sham 
animals (IRR: 14.7 ± 7.0 vs 35.0 ± 21.0 mm Hg/(mL/min), P < .001, 
Figure 5). Finally, glucose oxidation was significantly different be-
tween the 2 groups, as well as over the course of time, between 
brain-dead and sham animals (eµd 0.012, 95% CI [0.004, 0.03], main 
effect group P < .01, main effect time: P < .001, Figure 5), highlighting 
the significantly lower glucose oxidation levels during the reperfu-
sion period in brain-dead animals.
3.5 | Enzyme activities and gene expression
We evaluated the different enzymes involved in pyruvate metabolism 
to assess whether the observed changes could be explained by changes 
in enzyme activities of LDH, PDH, or ALT (Figure 6) or gene expression 
of LDHA and lactate transporters monocarboxylate transport (MCT)1, 
responsible for transferring lactate into cells and MCT4, which trans-
fers lactate out of glycolytic cells (Figure 6). At T = 4 hours, a significant 
reduction in LDH enzyme activity was observed in the kidney of brain-
dead animals (sham vs BD [T = 0], 0.50 ± 0.15 vs 0.61 ± 0.27 units/mg, 
P = .04, Figure 6). The activities of the remaining enzymes were not 
significantly different between the groups. The renal gene expression 
of MCT4, which transfers lactate out of glycolytic cells, was increased 
in brain-dead animals (sham vs BD: 0.73 ± 0.16 vs 1.2 ± 0.36, P < .01). 
No differences in gene expression of LDHA, MCT1, or MCT4 in the liver 
were found between groups (Figure 7).
3.6 | Decreased ATP levels in the liver following BD
To estimate cellular energy status in the liver and kidney, cellular ATP 
content was measured. In the liver of brain-dead animals, ATP levels were 
F I G U R E  4   Pyruvate metabolites in the liver and kidneys of sham and BD animals. The signal of each metabolite—A,D, lactate; B,E, 
alanine; or C,F, bicarbonate—is represented as the fraction of the sum of the metabolites (lactate + alanine +bicarbonate). Results are 
presented as the minimum, first quartile, median, third quartile, for each group at each of the different time points, where T = 0 represents 
the start of the BD period, and T = 2 and T = 4 2 and 4 hours later, n = 8 per group. BD, brain-dead
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reduced at T = 0 and T = 4 compared to sham animals (T = 0:29.0 ± 11.5 
vs 47.9 ± 7.5 µmol/g protein, P = .01; T = 4:30.8 ± 15.4 µmol/g protein, 
P = .04, Figure 8). ATP levels in the kidney were not different between 
groups (sham: 26.3 ± 10.8 µmol/g protein, T = 0:26.9 ± 11.3 µmol/g 
protein, T = 4:21.1 ± 8.9 µmol/g protein, Figure 8). These results sug-
gest a decreased bio-energetic efficiency in the liver following BD.
3.7 | Oxidative stress markers in tissue and plasma
Oxidative stress marker MDA was significantly increased in the 
plasma of brain-dead animals after 4 hours, when compared to sham 
animals and brain-dead animals at T = 0 (sham: 2.8 ± 0.41 mmol/L, 
BD T = 0:2.5 ± 0.33 mmol/L, BD T = 4:3.3 ± 0.38 mmol/L, P = .04 
and P < .01, respectively, Figure 9). MDA levels and gene expres-
sion of injury marker KIM-1, an early biomarker for BD-induced 
injury in the kidney, of brain-dead animals were not significantly 
different from sham animals (MDA - sham: 0.14 ± 0.03 µmol/g pro-
tein, T = 0:0.20 ± 0.10 µmol/g protein, T = 4:0.16 ± 0.04 µmol/g 
protein; for KIM-1 in the sham group: 0.14 ± 0.03 µmol/g protein, 
T = 0:0.20 ± 0.10 µmol/g protein, T = 4:0.16 ± 0.04 µmol/g protein, 
Figure 9).
4  | DISCUSSION
The primary finding in this study was that the liver and kidney have 
a distinctly different metabolic profile during BD, with a preference 
F I G U R E  5   Reduced glucose oxidation following brain death in the isolated perfused kidney. A, Perfusate flow. B, Ultrafiltrate production. 
C, Intrarenal vascular resistance. D, GFR (creatinine clearance). E, Glucose oxidation rates in the kidney of brain-dead and sham animals. 
Results are presented as mean ± SD, n = 6 per group
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for the production of alanine in the liver, yet lactate in the kidney. 
Secondly, lactate production increased in both organs immediately 
following BD induction, likely reflecting the hypoxic changes as a 
result of the hemodynamic instability before BD. Finally, metabolic 
assessment during machine perfusion of the kidneys showed a 
distinct reduction in glucose oxidation of brain-dead compared to 
sham animals. Together, this suggests that hyperpolarization MRI 
and glucose oxidation measurements are promising methods to 
visualize metabolic profiles during BD and subsequent renal reper-
fusion and to highlight differences between brain-dead and sham 
animals.
After BD induction, lactate increased and alanine decreased 
in the liver and kidneys. As BD induction is characterized by re-
duced perfusion of the abdominal organs,45 this likely reflects this 
hemodynamic instability and hypoxic changes. Similarly, lactate 
production increased during liver surgery42 and cardiac and renal 
ischemia-reperfusion injury.25,35,46 In each of these models, this 
likely results from a shift from aerobic to anaerobic glycolysis.35,47,48 
Increased lactate signals are potentially clinically relevant, as they 
have been correlated with a higher risk of early allograft dysfunction 
following liver49 and delayed graft function following kidney trans-
plantation.30 Despite these studies, there is currently insufficient 
evidence that lactate or any other specific biomarker has a strong 
prognostic value in predicting transplantation outcomes.30,50 With 
this in mind, it was interesting to observe that during machine per-
fusion, the level of glucose oxidation, and not renal creatinine clear-
ance, was significantly altered in kidneys from brain-dead animals. 
The majority of exogenous glucose, traced by d-[6-3H]glucose under 
aerobic conditions, undergoes oxidation, so quantification of 3H2O 
release is a reasonable marker of this final step in glucose metabo-
lism in the tricarboxylic acid cycle.51,52 However, it should be noted 
that 3H2O from d-[6-3H]glucose may be released during glycolysis 
because a proportion (6%-14%) of the 3H may be lost from the C6-
position by pyruvate kinase activity.53 Hence, a decreased 3H2O 
release may also reflect a diminished activity of pyruvate kinase in 
kidneys from BD donors. Nevertheless, liberation of 3H2O remains 
a valuable tool to detect differences in metabolic profiles between 
BD and sham kidneys.
Using 13C pyruvate in the MRI scan, we were able to visualize 
a distinctly different metabolic profile in the liver compared to the 
kidney. In sham animals, we observed a higher pyruvate-to-alanine 
conversion in the liver, yet increased pyruvate-to-lactate conversion 
rates in the kidneys. Interestingly, BD only enhanced this difference 
in both organs, with a trend towards increased lactate production 
in the kidneys (Figure 4). This was accompanied by an increase in 
gene expression of MCT4, which transfers lactate out of glycolytic 
cells. These changes could reflect a suppression of gluconeogene-
sis, increased lactate pools, and altered redox state as a result of 
F I G U R E  6   No difference in LDH, PDH, and ALT enzyme activities following brain death. Enzyme activities of A,B, LDH; C,D, PDH; and 
E,F, alanine transaminase (ALT) in the liver and kidney of sham and BD animals, determined after 4 h (in the case of sham and BD animals 
at T = 4) of experimental time or immediately after BD induction (BD animals at T = 0). Results are presented as mean ± SD, n = 8 in the 
sham and BD (T = 4) group, and n = 6 in the BD (T = 0) group. ALT, alanine transaminase; BD, brain-dead; LDH, lactate dehydrogenase; PDH, 
pyruvate dehydrogenase
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BD-induced hypoxia.54-56 This is supported by prior studies on the 
effects of BD in the kidney, showing that gluconeogenesis-related 
gene expression was decreased, while anaerobic, glycolytic-gene 
expression was increased.9 Furthermore, as BD progressed, oxi-
dative stress levels increased, while renal perfusion declined.9,12,57 
Therefore, the altered metabolic profile in the kidney during BD 
likely reflects increased anaerobic production of lactate and lower 
gluconeogenesis. Conversely, our results indicate that the liver main-
tained a steady pyruvate-to-alanine conversion as well as unaltered 
enzyme activities. As increased alanine and ALT activity has been as-
sociated with adequate cellular oxygen availability,58 these changes 
suggest that the liver maintains aerobic glycolysis. This idea is fur-
ther supported by a prior study that showed increased expression of 
glycolysis-related gene Pfk-1 as well as higher oxygen consumption 
in the liver during BD.9
Markers of hepatic and renal injury, oxidative stress, and tis-
sue energy status were used to validate the BD model. Our re-
sults confirm that BD resulted in increased hepatic and renal 
F I G U R E  7   No difference in LDHA, MCT1, and hepatic MCT4 gene expression following BD, yet increased MCT4 expression in the 
kidney. Gene expression of A,D LDHA; B,E MCT1; and C,F MCT4 in the liver and kidney of sham and brain-dead animals, determined after 
4 h (in the case of sham and brain-dead animals at T = 4) of experimental time or immediately after BD induction (brain-dead animals at 
T = 0). Results are presented as mean ± SD, n = 8. BD, brain death; LDHA, lactate dehydrogenase-A; MCT1, monocarboxylate transport 1
A B C
D E F
F I G U R E  8   Decreased ATP levels in the liver but not the kidneys following BD. A, ATP content in liver and B, kidney tissue determined 
after 4 h (in the case of sham and brain-dead animals at T = 4) of experimental time or immediately after BD induction (brain-dead animals 
at T = 0). Results are presented as mean ± SD, n = 7 in the sham and BD (T = 4) group, and n = 6 in the BD (T = 0) group. ATP, adenosine 
triphosphate; BD, brain death






















**    p < 0.01
10  |     van ERP Et al.
injury, in line with prior animal and human BD studies.7,9,12,13,39 
Furthermore, levels of oxidative stress increased as evidenced by 
higher plasma MDA levels. Finally, the cellular energy status was 
decreased in the liver, immediately after BD as well as 4 hours 
later. Even though ATP and MDA levels were not significantly 
changed in the kidney of brain-dead animals, our data show a 
trend of decreased energy levels and increased oxidative stress, 
similar to a prior study from our group.9 Altogether, this confirms 
that the adjustments made to our model to allow for the adminis-
tration of labeled pyruvate during BD did not impact the efficacy 
of our model.
This study has several limitations. As the main purpose of this 
study was to evaluate the potential of 2 metabolic assessment 
techniques, this study was not powered to statistically support 
some of the trends we observed in our data. Furthermore, we 
were unable to evaluate whether these metabolic changes can be 
correlated to organ quality or can be predictive of transplanta-
tion outcome. Finally, we observed no significant alterations in 
LDH, ALT, or PDH, indicating that changes in enzyme activities 
were probably not responsible for the changes in the metabolic 
profiles. Therefore, additional analyses on organ perfusion, ox-
ygenation, and several transporter proteins will need to be con-
ducted in a future study to assess whether the observed trends 
were affected by organ perfusion or limited by the uptake of any 
of the compounds.
In conclusion, this study shows that metabolic processes during 
BD in the liver and kidney can be visualized noninvasively using hy-
perpolarized MRI and also afterwards during ex vivo renal machine 
perfusion with assessment of glucose oxidation. Furthermore, these 
techniques can showcase the differences between metabolism in 
brain-dead compared to sham animals. We therefore believe this 
study lays the basis for future studies aimed at investigating and 
treating BD-induced metabolic changes and may be part of the key 
to improving transplantation outcomes.
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